Sean A. Power

Sean A. Power, listed as finance chief, appears in our data through filings on TG Therapeutics, Inc. shares, published by SEC (Form 4). In total, 44 filings cover trades dated from 30 April 2012 to 8 January 2026.

In open-market terms, that means 2 purchases worth €7,698 on one side and 23 sales worth €9.4M on the other. Taken together, the sales exceed the purchases by €9.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 18 share grants.

Most recently, on 9 January 2026, the filings show a share grant in TG Therapeutics, Inc. The clock since the last published purchase (17 September 2012) now reads 5,152 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.